The Board of Directors of Beijing Hotgen Biotech Co., Ltd. has authorized a buyback plan on February 7, 2024.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.44 CNY | +1.68% | +3.38% | -30.72% |
Apr. 16 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
Apr. 03 | Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024. | CI |
1st Jan change | Capi. | |
---|---|---|
-30.72% | 351M | |
-2.04% | 187B | |
-1.82% | 106B | |
-3.99% | 66.9B | |
+0.06% | 49.45B | |
+16.40% | 48B | |
+4.06% | 40.84B | |
+3.63% | 26.48B | |
+1.52% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Beijing Hotgen Biotech Co., Ltd. authorizes a Buyback Plan.